Nissan Chemical Corporation and Sanwa Kagaku Kenkyusho Co., Ltd., two Japanese companies, announced on April 4 their agreement to co-develop SK-2407/SN-001, which is a pre-clinical antisense oligonucleotide (ASO) candidate identified through their collaboration for...
Ataxia UK is a non-profit organisation that provides support to people with all types of ataxias, not just DRPLA. Ataxia UK organises virtual activities that may interest the DRPLA community: All About Ataxia The All About Ataxia is an information seminar organised by...
CureDRPLA is honored to announce that the American Epilepsy Society, another non-profit organization, has awarded funding to a research project to better understand epilepsy in DRPLA cell lines and mouse models. Epilepsy is very common in people with juvenile-onset...
Did you miss our meeting on December 4? Do not worry—we have got you covered! Dr Silvia Prades recorded her presentation to allow more people to learn about our work and updates. This talk included updates on our organization, the DRPLA Natural History and Biomarkers...
The International Congress for Ataxia Research (ICAR) was held in London on November 12-15. This was the biggest gathering of people interested in ataxia, with 600 attendees from 32 countries. The audience included scientists, clinicians and representatives from...